Effectiveness of 5-week Digital Respiratory Practice in Children With Duchenne and Becker Muscular Dystrophies.
DMDrespy2024
1 other identifier
interventional
12
1 country
1
Brief Summary
The purpose of this study is to analyze the effectiveness of a 5-weeks respiratory digital intervention program in patients with Duchenne muscular dystrophy and Becker muscular dystrophy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 22, 2024
CompletedFirst Posted
Study publicly available on registry
April 12, 2024
CompletedStudy Start
First participant enrolled
February 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedApril 1, 2025
March 1, 2025
6 months
March 22, 2024
March 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Analyze the improvement of the forced vital capacity (FVC).
Forced vital capacity is a respiratory parameter which is obtained from spirometry and which provides objective, valid information. It will be performed using spirometry before and after the digital respiratory intervention program. The spirometer that will be used is the "EasyOne Air Spirometer that complies with ISO 26782 standards, following the national spirometric recommendations of the ATS/ERS 2019.
Baseline, up to 5 weeks.
Secondary Outcomes (10)
Perform an anthropometric study of the patient's characteristics, taking into account weight; and also a general physical examination.
Baseline, up to 5 weeks.
Perform an anthropometric study of the patient's characteristics, taking into account age.
Baseline, up to 5 weeks.
Perform an anthropometric study of the patient's characteristics, taking into account height.
Baseline, up to 5 weeks.
Perform an anthropometric study of the patient's characteristics, taking into account sex.
Baseline, up to 5 weeks.
Examine changes in forced expiratory pressure
Baseline, up to 5 weeks.
- +5 more secondary outcomes
Study Arms (1)
Patients with Duchenne muscular dystrophy and Becker muscular dystrophy
EXPERIMENTALA group of 12 patients with Duchenne muscular dystrophy and Becker muscular dystrophy that will be following a digital respiratory physiotherapy program.
Interventions
A 4 times a week for a period of 5 weeks will be done, for a duration of 55-60 minutes (20 sessions), with an intensity adapted to the characteristics of each participant. Moreover, an intervention program will be used based on respiratory muscle training exercises, upper limb strength work, yoga, diaphragmatic awareness exercises, always trying to do them through the use of games, and even try to include exercises that use motor imagery. The intervention program is carried out and stimulated through videos and therapeutic teaching to the caregivers in the first evaluation session, as well as as well as with a weekly follow-up using WhatsApp or Zoom as forms of communication, or a telephone call to ensure correct follow-up of the intervention program. Moreover, YouTube videos, own videos prepared by the physiotherapy will be used to help optimally resolve doubts that arise when carrying out the program by video call.
Eligibility Criteria
You may qualify if:
- Participants with Duchenne muscular dystrophy and patients with Becker muscular dystrophy will be chosen.
- Aged between 5 and 20 years.
- Child who could walk and follow the intervention program, and were diagnosed according to the International Classification of Diseases, 10 Revision. code (G71-01); and who had an NSSA score greater than 20.
You may not qualify if:
- Patients who present associated heart disease.
- Patients who presentor fractures, a heart rate greater than 120 beats per minute, or an oxygen saturation less than 89% will be excluded.
- Participants who do not have the capacity to have internet at home to perform the intervention, as well as all patients whose caregivers did not agree to sign the informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rocío Martín-Valero
Málaga, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Rocío Martín-Valero, PhD
University of Malaga
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 22, 2024
First Posted
April 12, 2024
Study Start
February 5, 2025
Primary Completion
July 30, 2025
Study Completion
December 30, 2025
Last Updated
April 1, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share